Adoptive Cellular Immunotherapy for Progressive Multifocal Leukoencephalopathy With Ex Vivo Generated Polyomavirus-Specific T-Cells

NCT02694783 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

COMPLETED

Status

60

Enrollment

NIH

Sponsor class

Conditions

Progressive Multifocal Leukoencephalopathy

Interventions

BIOLOGICAL: PyVST

Sponsor

National Institute of Neurological Disorders and Stroke (NINDS)